Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Dasatinib Overcomes AML Resistance to BCL2 Inhibition By Indirectly Inhibiting MCL1: From Ex Vivo drug Sensitivity/Resistance Profiling to a Phase II Clinical Trial: A Hemato-BIO Study

Sylvain Garciaz, Rémy Castellano, Arnaud Jacquel, Arnaud Guille, Maxence Bourgoin, Camille Montersino, José Adélaïde, Patrick Auberger, Daniel Birnbaum, Marie Anne Hospital, Yves Collette, Norbert Vey

Blood (2024) 144 (Supplement 1): 1378.

https://doi.org/10.1182/blood-2024-207352

Published: 2024

Journal Articles

DIACC2010, Sole-in-Class Selective Inhibitor of Kinesin KIF20A, Has Potent Preclinical Efficacy in Acute Myeloid Leukemia

Sylvain Garciaz, Yves Collette, Remy Castellano, Michel Aurrand-Lions, Helene Sicard, Laetitia Jentreau, Norbert Vey, Cecile Bougeret

Blood (2022) 140 (Supplement 1): 7800–7801.

https://doi.org/10.1182/blood-2022-166820

Published: 2022

Journal Articles

An Autosomal Dominant Form of Ras-Related C3 Botulinum Toxin Substrate 2 (RAC2) Is Associated with Haematopoiesis Failure

Chantal Lagresle-Peyrou, Aurélien Olichon, Hanem Sadek, Philippe Roche, Claudine Tardy, Natael Sorel, Boris Bessot, Cindy Da Silva, Alain Fischer, Despina Moshous, Yves Collette, Capucine Picard, Jean-Laurent Casanova, Isabelle André, Marina Cavazzana

Blood (2021) 138 (Supplement 1): 4306.

https://doi.org/10.1182/blood-2021-150114

Published: 2021

Journal Articles

An Autosomal Dominant SCID Form Due to a Gain of Function Mutation in the RAC2 Gene

Chantal Lagresle-Peyrou, PhD, Aurélien Olichon, Hanem Sadek, Philippe Roche, Claudine Tardy, Cindy Da Silva, Alexandrine Garrigue, Alain Fischer, MD PhD, Despina Moshous, MD PhD, Yves Collette, Capucine Picard, MD PhD, Jean-Laurent Casanova, PhD MD, Isabelle André, PhD, Marina Cavazzana, MD PhD

Blood (2019) 134 (Supplement_1): 3742.

https://doi.org/10.1182/blood-2019-126855

Published: 2019

Journal Articles

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Norbert Vey, MD PhD, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, Aude Charbonnier, Bilal Mohty, MD, Evelyne D'Incan, Jerome Rey, Remy Castellano, Camille Montersino, Max Chaffanet, Nadine Carbuccia, Jose Adelaide, Benjamin Bouchacourt, Arnaud Guille

Blood (2018) 132 (Supplement 1): 1401.

https://doi.org/10.1182/blood-2018-99-119263

Published: 2018

Journal Articles

Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy

Ruxanda Moschoi, Véronique Imbert, Marielle Nebout, Johanna Chiche, Didier Mary, Thomas Prebet, Estelle Saland, Rémy Castellano, Laurent Pouyet, Yves Collette, Norbert Vey, Christian Chabannon, Christian Recher, Jean-Emmanuel Sarry, Damien Alcor, Jean-François Peyron, Emmanuel Griessinger

Blood (2016) 128 (2): 253–264.

https://doi.org/10.1182/blood-2015-07-655860

Published: 2016

Includes: Supplemental data

Journal Articles

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

Caroline Veuillen, PhD, Jerome Rey, MD, Rémy Castellano, PhD, Florence Orlanducci, Françoise Mallet, Sylvaine Just-Landi, Diane Coso, MD, Vadim Ivanov, MD, PhD, Xavier Carcopino, MD, Reda Bouabdallah, MD, Yves Collette, PhD, Cyril Fauriat, PhD, Daniel Olive, MD, PhD, Thérèse Aurran, MD

Blood (2011) 118 (21): 3876.

https://doi.org/10.1182/blood.V118.21.3876.3876

Published: 2011

Journal Articles

Anti-Acute Myeloid Leukemia Activity of Chaetocin, a Novel Epigenetic Drug Inhibitor Inducing Oxidative Stress.

Hassiba Chaib, BSc, Thomas Prebet, MD, Audrey Restouin, BSc, Remy Castellano, PhD, Sandrine Opi, PhD, Daniel Olive, MD, PhD, Jean Paul Borg, PD, PhD, Norbert Vey, MD, Yves Collette, PhD

Blood (2007) 110 (11): 889.

https://doi.org/10.1182/blood.V110.11.889.889

Published: 2007

Journal Articles

Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD4 + T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway

Giorgio Zauli, Davide Gibellini, Paola Secchiero, Hélène Dutartre, Daniel Olive, Silvano Capitani, Yves Collette

Blood (1999) 93 (3): 1000–1010.

https://doi.org/10.1182/blood.V93.3.1000

Published: 1999

NARROW

Dasatinib Overcomes AML Resistance to BCL2 Inhibition By Indirectly Inhibiting MCL1: From Ex Vivo drug Sensitivity/Resistance Profiling to a Phase II Clinical Trial: A Hemato-BIO Study

DIACC2010, Sole-in-Class Selective Inhibitor of Kinesin KIF20A, Has Potent Preclinical Efficacy in Acute Myeloid Leukemia

An Autosomal Dominant Form of Ras-Related C3 Botulinum Toxin Substrate 2 (RAC2) Is Associated with Haematopoiesis Failure

An Autosomal Dominant SCID Form Due to a Gain of Function Mutation in the RAC2 Gene

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

Anti-Acute Myeloid Leukemia Activity of Chaetocin, a Novel Epigenetic Drug Inhibitor Inducing Oxidative Stress.

Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD4 + T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only